(Q46349815)

English

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies

scientific article published on 24 September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

author name string

Mark R Stein

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

Robert P Nelson

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

Joseph A Church

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

Richard L Wasserman

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

Michael Borte

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

Christiane Vermylen

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

Johann Bichler

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

IgPro10 in PID study group

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

publication date

24 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

29

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

137-144

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

https://scigraph.springernature.com/pub.10.1007/s10875-008-9231-2

0 references

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

1 reference

https://api.crossref.org/works/10.1007%2FS10875-008-9231-2

21 January 2018

Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amino acid kinetics in patients with sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of proline in the prevention of aggregation during protein folding in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of intravenous immune globulin in immunodeficiency diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human intravenous immunoglobulin in primary and secondary antibody deficiencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks associated with the use of intravenous immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agammaglobulinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigations of prion and virus safety of a new liquid IVIG product.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18814020

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10875-008-9231-2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18814020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46349815&oldid=2107463011"